Watchlist Price Alert

Recursion Pharmaceuticals... (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

5.49

0.92 (20.13%)

At close: Jun 06, 2025, 3:59 PM

Recursion Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-463.66M	-328.07M	-239.48M	-186.48M	-87.01M	-61.88M
Depreciation & Amortization	36.49M	24.4M	11.76M	8.4M	4.44M	2.49M
Stock-Based Compensation	81.69M	53.5M	27.91M	14.84M	4.29M	1.39M
Other Working Capital	-38.37M	-49.27M	103.15M	-10M	26.67M	775K
Other Non-Cash Items	-13.7M	12.64M	11.37M	4.1M	282K	-499K
Deferred Income Tax	n/a	n/a	n/a	827K	1.76M	1.05M
Change in Working Capital	n/a	-50.26M	104.92M	-306K	30.83M	408K
Operating Cash Flow	-359.17M	-287.78M	-83.52M	-158.61M	-45.4M	-57.04M
Capital Expenditures	-13.7M	-11.96M	-37.36M	-39.8M	-6.74M	-3.91M
Cash Acquisitions	277.1M	1.84M	n/a	231.95M	-2.6M	n/a
Purchase of Investments	n/a	n/a	n/a	-301.14M	n/a	n/a
Sales Maturities Of Investments	n/a	480K	230.61M	69.19M	n/a	n/a
Other Investing Acitivies	-3.35M	-597K	230.31M	-231.95M	595K	n/a
Investing Cash Flow	260.06M	-10.23M	193.25M	-271.74M	-8.74M	-3.91M
Debt Repayment	-4.44M	-766K	-90K	-12.8M	6.32M	705K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	8.14M	12.81M	10.72M	8.44M	681K	-210K
Financial Cash Flow	304.12M	140.13M	154.34M	458.54M	246.13M	120.41M
Net Cash Flow	201.6M	-157.69M	263.76M	28.18M	192M	59.46M
Free Cash Flow	-372.87M	-300.33M	-120.88M	-198.41M	-52.13M	-60.95M